ribavirin has been researched along with cholecalciferol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bignulin, S; Bitetto, D; Cmet, S; Cussigh, A; Fabris, C; Falleti, E; Fontanini, E; Fornasiere, E; Fumolo, E; Martinella, R; Pipan, C; Pirisi, M; Toniutto, P | 1 |
| Imawari, M; Kato, T; Masaki, T; Matsumura, T; Murayama, A; Sugiyama, N; Tasaka-Fujita, M; Wakita, T | 1 |
| Ahmed, A; Assem, N; Doss, W; El Kassas, M; El Raziky, M; Elsharkawy, A; Esmat, G; Hassany, M; Sabry, D | 1 |
| Asabe, S; Funyu, J; Hashimoto, Y; Hosoda, Y; Inao, M; Koshima, Y; Mochida, S; Nakayama, N; Nishikawa, K; Omori-Mizuno, Y; Tanaka, M; Tomita, K; Yakabi, K | 1 |
| Asselah, T; Cacoub, P; Carrat, F; Lapidus, N; Pol, S; Ratziu, V; Serfaty, L; Souberbielle, JC; Terrier, B; Thibault, V | 1 |
3 trial(s) available for ribavirin and cholecalciferol
| Article | Year |
|---|---|
Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.
Topics: Adolescent; Adult; Antiviral Agents; Cholecalciferol; Dietary Supplements; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Young Adult | 2015 |
Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.
Topics: Administration, Ophthalmic; Aged; Antiviral Agents; Biomarkers; Calcifediol; Cholecalciferol; Drug Synergism; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hydroxycholecalciferols; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Up-Regulation | 2015 |
Vitamin D in addition to peg-interferon-alpha/ribavirin in chronic hepatitis C virus infection: ANRS-HC25-VITAVIC study.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Calcifediol; Cholecalciferol; Drug Therapy, Combination; Female; France; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Intention to Treat Analysis; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Outcome; Viral Load; Vitamin D Deficiency; Vitamins | 2015 |
3 other study(ies) available for ribavirin and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Cholecalciferol; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Vitamin D; Vitamin D Deficiency | 2011 |
25-Hydroxyvitamin D3 suppresses hepatitis C virus production.
Topics: Antiviral Agents; Calcifediol; Cell Proliferation; Cell Survival; Cells, Cultured; Cholecalciferol; Dose-Response Relationship, Drug; Hepacivirus; Hepatitis C; Hepatocytes; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Sampling Studies; Sensitivity and Specificity | 2012 |